AKZA — Akzo Nobel NV Balance Sheet
0.000.00%
- €9.63bn
- €13.98bn
- €10.71bn
- 68
- 43
- 57
- 57
Annual balance sheet for Akzo Nobel NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,842 | 1,196 | 1,775 | 1,718 | 1,448 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,019 | 2,451 | 2,557 | 2,578 | 2,606 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,064 | 5,348 | 6,244 | 6,044 | 5,836 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,945 | 2,104 | 2,259 | 2,296 | 2,440 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,177 | 13,878 | 14,741 | 14,558 | 14,249 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,093 | 4,869 | 5,746 | 5,706 | 4,730 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 7,431 | 8,453 | 10,408 | 10,236 | 9,675 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5,746 | 5,425 | 4,333 | 4,322 | 4,574 |
Total Liabilities & Shareholders' Equity | 13,177 | 13,878 | 14,741 | 14,558 | 14,249 |
Total Common Shares Outstanding |